China Pharma Holdings, Inc.
CPHI
$1.80
-$0.04-1.96%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -26.28% | -9.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -26.28% | -9.72% | |||
| Cost of Revenue | -26.68% | -12.54% | |||
| Gross Profit | 31.38% | 36.08% | |||
| SG&A Expenses | -2.94% | -8.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.38% | -19.40% | |||
| Operating Income | -25.19% | 33.90% | |||
| Income Before Tax | -23.30% | 32.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.30% | 32.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.30% | 32.74% | |||
| EBIT | -25.19% | 33.90% | |||
| EBITDA | -50.44% | 57.93% | |||
| EPS Basic | -3.83% | 32.72% | |||
| Normalized Basic EPS | -3.85% | 32.76% | |||
| EPS Diluted | -3.83% | 32.72% | |||
| Normalized Diluted EPS | -3.85% | 32.76% | |||
| Average Basic Shares Outstanding | 18.76% | 0.00% | |||
| Average Diluted Shares Outstanding | 18.76% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||